128 related articles for article (PubMed ID: 30952594)
1. Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors.
Nielsen AJ; Raez-Villanueva S; Crankshaw DJ; Holloway AC; McNulty J
Bioorg Med Chem Lett; 2019 Jun; 29(11):1395-1398. PubMed ID: 30952594
[TBL] [Abstract][Full Text] [Related]
2. Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1).
McNulty J; Keskar K; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2014 Sep; 24(18):4586-4589. PubMed ID: 25155384
[TBL] [Abstract][Full Text] [Related]
3. A new Suzuki synthesis of triphenylethylenes that inhibit aromatase and bind to estrogen receptors α and β.
Zhao LM; Jin HS; Liu J; Skaar TC; Ipe J; Lv W; Flockhart DA; Cushman M
Bioorg Med Chem; 2016 Nov; 24(21):5400-5409. PubMed ID: 27647367
[TBL] [Abstract][Full Text] [Related]
4. Investigation of aryl halides as ketone bioisosteres: refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
McNulty J; Nielsen AJ; Brown CE; DiFrancesco BR; Vurgun N; Nair JJ; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2013 Nov; 23(22):6060-3. PubMed ID: 24113062
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones.
Cagir A; Odaci B; Varol M; Akcok I; Okur O; Koparal AT
Anticancer Agents Med Chem; 2018 Feb; 17(14):1915-1923. PubMed ID: 28554313
[TBL] [Abstract][Full Text] [Related]
6. Optimization of the aromatase inhibitory activities of pyridylthiazole analogues of resveratrol.
Mayhoub AS; Marler L; Kondratyuk TP; Park EJ; Pezzuto JM; Cushman M
Bioorg Med Chem; 2012 Apr; 20(7):2427-34. PubMed ID: 22386564
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors.
Di Matteo M; Ammazzalorso A; Andreoli F; Caffa I; De Filippis B; Fantacuzzi M; Giampietro L; Maccallini C; Nencioni A; Parenti MD; Soncini D; Del Rio A; Amoroso R
Bioorg Med Chem Lett; 2016 Jul; 26(13):3192-3194. PubMed ID: 27161804
[TBL] [Abstract][Full Text] [Related]
8. New 7,8-benzoflavanones as potent aromatase inhibitors: synthesis and biological evaluation.
Yahiaoui S; Fagnere C; Pouget C; Buxeraud J; Chulia AJ
Bioorg Med Chem; 2008 Feb; 16(3):1474-80. PubMed ID: 18042388
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of synthesized coumarin derivatives on aromatase inhibitory activity.
Yamaguchi Y; Nishizono N; Kobayashi D; Yoshimura T; Wada K; Oda K
Bioorg Med Chem Lett; 2017 Jun; 27(12):2645-2649. PubMed ID: 28512028
[TBL] [Abstract][Full Text] [Related]
10. Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase).
McNulty J; Nair JJ; Vurgun N; Difrancesco BR; Brown CE; Tsoi B; Crankshaw DJ; Holloway AC
Bioorg Med Chem Lett; 2012 Jan; 22(1):718-22. PubMed ID: 22079757
[TBL] [Abstract][Full Text] [Related]
11. Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives.
Bonfield K; Amato E; Bankemper T; Agard H; Steller J; Keeler JM; Roy D; McCallum A; Paula S; Ma L
Bioorg Med Chem; 2012 Apr; 20(8):2603-13. PubMed ID: 22444875
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of resveratrol analogues as aromatase and quinone reductase 2 inhibitors for chemoprevention of cancer.
Sun B; Hoshino J; Jermihov K; Marler L; Pezzuto JM; Mesecar AD; Cushman M
Bioorg Med Chem; 2010 Jul; 18(14):5352-66. PubMed ID: 20558073
[TBL] [Abstract][Full Text] [Related]
13. Lead optimization of 4-imidazolylflavans: new promising aromatase inhibitors.
Yahiaoui S; Pouget C; Buxeraud J; Chulia AJ; Fagnère C
Eur J Med Chem; 2011 Jun; 46(6):2541-5. PubMed ID: 21497425
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors.
Fantacuzzi M; De Filippis B; Gallorini M; Ammazzalorso A; Giampietro L; Maccallini C; Aturki Z; Donati E; Ibrahim RS; Shawky E; Cataldi A; Amoroso R
Eur J Med Chem; 2020 Jan; 185():111815. PubMed ID: 31732252
[TBL] [Abstract][Full Text] [Related]
15. 2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitors.
Lézé MP; Le Borgne M; Marchand P; Loquet D; Kogler M; Le Baut G; Palusczak A; Hartmann RW
J Enzyme Inhib Med Chem; 2004 Dec; 19(6):549-57. PubMed ID: 15662958
[TBL] [Abstract][Full Text] [Related]
16. QSAR modeling of aromatase inhibitory activity of 1-substituted 1,2,3-triazole analogs of letrozole.
Nantasenamat C; Worachartcheewan A; Prachayasittikul S; Isarankura-Na-Ayudhya C; Prachayasittikul V
Eur J Med Chem; 2013 Nov; 69():99-114. PubMed ID: 24012714
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 5-[(aryl)(1H-imidazol-1-yl)methyl]-1H-indoles: potent and selective aromatase inhibitors.
Lézé MP; Le Borgne M; Pinson P; Palusczak A; Duflos M; Le Baut G; Hartmann RW
Bioorg Med Chem Lett; 2006 Mar; 16(5):1134-7. PubMed ID: 16380254
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biochemical studies of 17-substituted androst-3-enes and 3,4-epoxyandrostanes as aromatase inhibitors.
Cepa MM; Tavares da Silva EJ; Correia-da-Silva G; Roleira FM; Teixeira NA
Steroids; 2008 Dec; 73(14):1409-15. PubMed ID: 18691607
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and aromatase inhibitory evaluation of 4-N-nitrophenyl substituted amino-4H-1,2,4-triazole derivatives.
Song Z; Liu Y; Dai Z; Liu W; Zhao K; Zhang T; Hu Y; Zhang X; Dai Y
Bioorg Med Chem; 2016 Oct; 24(19):4723-4730. PubMed ID: 27567077
[TBL] [Abstract][Full Text] [Related]
20. New aromatase inhibitors from the 3-pyridyl arylether and 1-aryl pyrrolo[2,3-c]pyridine series.
Stauffer F; Furet P; Floersheimer A; Lang M
Bioorg Med Chem Lett; 2012 Mar; 22(5):1860-3. PubMed ID: 22335894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
